Nitrowave RF cable assemblies offer improved stability with flexure and Nitrowave cable technology in distinctive Samtec ...
REDWOOD CITY, Calif., September 11, 2025--(BUSINESS WIRE)--Box, Inc. (NYSE:BOX), the leading Intelligent Content Management (ICM) platform, today announced Box Shield Pro, a powerful new suite of ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Box, Inc. (NYSE:BOX), the leading Intelligent Content Management (ICM) platform, today announced Box Shield Pro, a powerful new suite of security capabilities ...
Box recently introduced innovative AI-driven products, enhancing its market offerings such as Box Extract and Box Automate. These product releases highlight the company's commitment to improving data ...
The Register on MSN
Square Kilometre Array is so sensitive, its datacenter needs two Faraday cages to stop RF leaks
Stray signals are a no-no when you’re trying to tune into the stars IAC 2025 Work on the datacenter that serves the Square Kilometre Array’s (SKA’s) site in Western Australia is all but complete, ...
Motorcycle.com on MSN
Huge Discounts: This Week's Best Motorcycle Gear Deals!
–We’re constantly on the look for great deals on motorcycle gear. We’ll be updating this post each week with the latest sales ...
PALO ALTO - Guardant Health, Inc. (NASDAQ:GH), whose stock has surged over 167% in the past year and is currently trading near its 52-week high of $68, announced clinical validation results for the ...
The film industry, for the last few weeks, has had a lot to offer to the audience at the box office. But Monday was a bit dull in terms of the earnings of the films. While several films earned well on ...
Strategic partnership will expand Shield to PathGroup’s 15,000+ primary care and OBGYN physicians PathGroup’s extensive network of phlebotomists and Patient Service Centers enables easier access to ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced a strategic partnership with PathGroup, one of the nation’s leading partners to physicians, hospitals, and ...
Latest algorithm (Shield V2) has sensitivity of 84% for colorectal cancer with specificity of 90%, with stage I sensitivity of 62% Performance of the Shield algorithm was validated in expanded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback